Nebraska Business Press
SEE OTHER BRANDS

Following business and economy news from Nebraska

Single-use Pump Market Size to Project USD 2,133.2 Million by 2034

The global single-use pump market is valued at USD 606.34 million in 2025 and is projected to reach approximately USD 2,133.2 million by 2034, expanding at a compound annual growth rate (CAGR) of 15.95% over the forecast period.

Ottawa, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The global single-use pump market size estimated at USD 523.65 million in 2024, is anticipated to grow to USD 2,133.2 million by 2034, reflecting a strong CAGR of 15.95%, according to a report by Towards Healthcare, a sister firm of Precedence Research.

The growth of the market is driven by the growing biopharmaceutical industry, which increases the production of biologics and personalized medicine, which fuels the growth of the market.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5372

Key Takeaways

  • North America dominated the global single-use pump market by 41% in 2023
  • The Asia Pacific region is anticipated to witness the fastest growth during the forecast period.
  • By product, the equipment segment held the majority share of the single-use pump market.
  • By material, the Polypropylene (PP) pump segment held the largest share in the single-use pump market.
  • By end use, the biopharmaceutical & pharmaceutical companies segment held the largest market.

Market Overview & Potential

The single-use pump market is growing rapidly because the single-use pump has many advantages, such as reducing sterilization and cleaning costs, eliminating contamination, easy coating replacement, and faster pump operation. Single-use pumps are available for a variety of applications based on customer needs. Consistency and accuracy, proper pressure and flow, low energy and low shear, low heat input, and reliable pump equipment to ensure consistent equipment. This can be achieved by using a single-use quadruple diaphragm in biopharmaceutical production. The main advantage of these pumps, whether used in stainless steel or single-use setups, is their specific mode of operation. Single-use pumps allow major biopharmaceutical companies to eliminate the high costs of cleaning and operating pumps and systems.

What Is The Growth Potential Responsible For The Growth Of The Single-Use Pump Market?

The growth of the single-use pump market is driven by the growing biopharmaceutical industry, which increases the demand for production of biologics like monoclonal antibodies and vaccines, which uses single use single-use pumps for processes for efficient and contamination-free manufacturing, which fuels the growth of the market. The growing demand for personalized medicine also uses single-use systems, which offer the necessary scalability and adaptability for these therapies, fueling the growth. The other key drivers are operational efficiency and cost reduction, technological advancements, regulatory support, and sustainability, and market expansion, which boost the growth of the market.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What Are The Growing Trends Associated With The Single-Use Pump Market?

Technological Advancements

  • The improved and enhanced e-design, material, and performance through interaction of smart technology and integration of IoT fuels the growth of the market.

Rising Adoption Of Single-Use Technologies In Biomanufacturing

  • The shift of the biopharmaceutical industry towards the use of single-use systems due to its advantages associated with it fuels the growth of the market.

Regulatory Support

  • The simplified validation processes and reduced burden of cleaning and sterilization influence the growth.

Sustainability And Eco-Friendliness

  • The growing awareness and regulation for the use of sustainable and eco-friendly single-use pumps influences the eco-friendly manufacturing practices.

What Is The Growing Challenge In The Single-Use Pump Market?

The key challenges that hinder the growth of the market are environmental concerns, high initial investments, compatibility and standardization, performance variability, extractables and leachables, supply chain disruption, regulatory landscape, and scalability. These factors affect profitability and also the cost of the final product, limiting growth. These are a few challenges that limit the growth and expansion of the market.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

Regional Analysis

How Did North America Dominate The Single-Use Pump Market In 2024?

North America dominates the single-use pump market in 2024. North America remains a key market for single-use pumps, supported by the strong presence of biopharmaceutical companies and advanced healthcare infrastructure. The region emphasizes rapid innovation, with pharmaceutical manufacturers adopting disposable technologies to enhance productivity and compliance with stringent regulatory frameworks. Increasing investments in biologics, monoclonal antibodies, and cell and gene therapies create high demand for sterile, efficient fluid handling systems. The U.S., in particular, leads adoption due to robust r&d funding and frequent collaborations between biotech startups and large pharmaceutical firms. This focus on innovation and efficiency ensures North America maintains a leading role in the global market.

What Made The Asia Pacific Significantly Grow In The Single-Use Pump Market In 2024?

Asia Pacific is emerging as a fast-growing region for single-use pumps, driven by expanding pharmaceutical manufacturing, rising healthcare investments, and supportive government initiatives. Countries like China, India, South Korea, and Singapore are strengthening their biopharmaceutical industries, which boosts demand for efficient, sterile fluid handling systems. The affordability, ease of deployment, and regulatory advantages of single-use pumps make them highly attractive for regional manufacturers seeking to align with international standards. Additionally, the growing clinical trials and vaccine production capacity in the region further accelerate adoption. Asia Pacific is thus positioning itself as a hub for scalable, cost-efficient bioprocessing solutions.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Segmental Insights

By Product,

How Did The Equipment Segment Dominate The Single-Use Pump Market In 2024?

The equipment segment held the majority share of the single-use pump market. The equipment segment in the single-use pump market is vital as it ensures sterile and efficient fluid transfer in pharmaceutical and biopharmaceutical processes. These pumps are designed for disposable use, reducing the risks of contamination and cross-batch interference. Their adoption is driven by flexibility, faster turnaround in manufacturing, and suitability for high-purity applications. Companies prefer these pumps as they minimize downtime associated with cleaning and sterilization, aligning with modern production models focused on efficiency. The equipment also supports continuous bioprocessing and high-value drug production, making it a central component of single-use technology ecosystems in life sciences.

By material,

Which Material Segment Dominates the Single-Use Pump Market In 2024?

The polypropylene (PP) pump segment held the largest share in the single-use pump market. Polypropylene pumps dominate the material category due to their chemical resistance, durability, and compatibility with a wide range of bioprocess fluids. Their lightweight structure and ease of integration make them a preferred choice for pharmaceutical facilities aiming for cost-effective, safe, and sterile fluid handling. Polypropylene also supports gamma irradiation sterilization, enhancing its acceptance in regulated environments. With increasing reliance on single-use systems, these pumps reduce risks of contamination while maintaining mechanical stability. The material’s adaptability in complex drug formulations and vaccine production processes further enhances its role in modern biopharmaceutical workflows, ensuring reliability in large and small-scale applications.

By End Use,

Which End Use Segment Dominates the Single-Use Pump Market In 2024?

The biopharmaceutical & pharmaceutical companies segment held the largest market. Biopharmaceutical and pharmaceutical companies represent the largest end-use segment, relying on single-use pumps to streamline production and maintain sterility standards. These organizations benefit from the pumps’ ability to handle sensitive biologics, cell cultures, and drug formulations without cross-contamination risks. The technology allows flexibility in scaling production, supporting clinical trials and commercial manufacturing alike. Single-use pumps also align with regulatory compliance by eliminating cleaning validation requirements. With rising demand for biologics, vaccines, and advanced therapeutics, pharma companies increasingly invest in disposable solutions that optimize efficiency and reduce operational complexities, making single-use pumps a cornerstone of their modern manufacturing infrastructure.

Browse More Insights of Towards Healthcare:

The global breast pump market is estimated at USD 3.23 billion in 2024 and is expected to reach USD 3.52 billion in 2025. By 2034, the market is projected to grow to approximately USD 7.58 billion, reflecting a robust CAGR of 8.63% between 2025 and 2034.

The South Korea breast pump market is valued at USD 20.41 million in 2024, growing to USD 21.93 million in 2025, and is anticipated to reach USD 41.66 million by 2034, at a CAGR of 7.44% over the same period.

The insulin pump market is set to expand at a CAGR of 9.65%, rising from USD 6.87 billion in 2024 to an estimated USD 17.25 billion by 2034.

The global single-cell sequencing market is projected to grow steadily from USD 1.63 billion in 2024 to USD 1.88 billion in 2025, eventually surpassing USD 6.65 billion by 2034, at a CAGR of 15.05%.

The single-use assemblies market is valued at USD 13.25 billion in 2024, increasing to USD 15.39 billion in 2025, and expected to reach around USD 58.44 billion by 2034, expanding at a CAGR of 16.15%.

The single-use downstream bioprocessing market is estimated at USD 1.57 billion in 2024, growing to USD 1.79 billion in 2025, and projected to reach USD 5.9 billion by 2034, reflecting a CAGR of 14.24%.

The single-use sensors market is set to grow from USD 0.47 billion in 2024 to USD 0.54 billion in 2025, reaching USD 1.86 billion by 2034, at a CAGR of 15.04%.

The single-cell analysis market is estimated at USD 5.19 billion in 2024, growing to USD 6.16 billion in 2025, and projected to reach USD 29.15 billion by 2034, at a CAGR of 18.74%.

The single nucleotide polymorphism (SNP) genotyping market is expected to grow from USD 6.48 billion in 2024 to USD 7.24 billion in 2025, reaching USD 19.48 billion by 2034, at a CAGR of 11.7%.

The single-cell omics market is forecasted to rise from USD 1.94 billion in 2024 to USD 2.35 billion in 2025 and is anticipated to reach USD 12.05 billion by 2034, expanding at a CAGR of 16.14%.

Recent Developments

  • In June 2024, Ingersoll Rand Inc., a global provider of mission-critical process and industrial solutions, completed a previously announced agreement to acquire ILC Dover and Air and Power Equipment (CAPS), Del PD Pumps and Gear Pvt Ltd. (Del Pumps), and Fruvac Ltd. for a total value of approximately US$150 million.
  • In May 2023, Getinge announced an agreement to acquire High Purity New England, Inc., an American company addressing the rapidly growing challenges of single-use purification solutions for bioprocessing applications.
  • In May 2024, Novo Holdings A/S announced that it had agreed to acquire a majority stake in Single Use Support. This life sciences company rapidly provides solutions to the pharmaceutical industry to solve their manufacturing processes.

Single-use Pump Market Key Players

  • Dover Corp.
  • Spirax-Sarco Engineering plc.
  • Colly Flowtech
  • Levitronix
  • PumpCell
  • Fluid Flow Products, Inc.
  • PerfuseCell A/S
  • ALMATECHNIK AG
  • ESI Technologies Ltd.
  • Avantor Inc.

Segments Covered in The Report

By Product

  • Equipment
    • Peristaltic pumps
    • Quaternary diaphragm pump
    • Centrifugal pumps
    • Others
  • Accessories

By Material

  • Polypropylene (PP) Pumps
  • Polyethylene (PE) Pumps
  • Others

By End-use

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5372

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire

Find us on social platforms: LinkedInTwitterInstagram | Medium | Pinterest


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions